Canagliflozin aids additional weight loss after refractory bariatric surgery

Adults who underwent bariatric surgery and experienced diabetes remission but later regained weight and redeveloped the disease experienced weight loss and improvements in cardiometabolic parameters after 6 months of canagliflozin therapy, according to study data presented at the AACE Annual Scientific and Clinical Congress.

Source: Canagliflozin aids additional weight loss after refractory bariatric surgery

About the Author

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. Connect on Linkedin